Call for Abstracts
INMIS will provide up-to-date information on key areas in maternal and neonatal immunization. This major symposium will provide the opportunity for international stakeholders from the entire spectrum of vaccinology research – laboratory science and clinical trials through to implementation and social science of immunization programs to share the latest progress on maternal and neonatal immunization. Abstracts that are accepted will be assigned to either oral or poster presentation.
Abstract submissions will be open in January, 2019 and close on April 1, 2019.
Submission of Abstracts
Abstracts describing neonatal and maternal immunization research and implementation will be evaluated in the following themes:
- Pre-clinical: including vaccine development and laboratory science;
- Clinical: including methodology, epidemiology of vaccine preventable diseases, Phase I-IV clinical trials, prevention of disease transmission, vaccine safety and impact of the microbiome;
- Programmatic: including vaccine implementation, vaccine acceptance and hesitancy, ethics, economics, modelling, program evaluation, vaccine coverage, post-marketing surveillance, disease impact.
Abstract selection and presentation (Abstract submissions will open in January 2019).
Abstracts must be submitted via the online abstract submission system using the template provided on the system. All submitted abstracts will be reviewed by the scientific committee and, if accepted, will be allocated to an oral or poster session.
Abstracts must be original and must not have been published prior to the INMIS 2019 meeting. Closing date for abstract submission is Monday, April 1, 2019. Only abstracts submitted via the online submission system will be reviewed by the scientific committee. Abstracts submitted by other means will not be considered for review.
Abstracts are to be submitted in English, and should not exceed 300 words, excluding title and authors. Abstracts are to include introduction/background & aims, methods, results and conclusions. The presenting author is required to ensure that all co-authors have approved the abstract before submission.
Notification of acceptance will be made by May 7, 2019. Presenting authors must register and pay for their registration by July 31, 2019. Please note that travel VISAs for entry into Canada may be required by some attendees. It may take up to 3 months to obtain a VISA. Information on travel to Canada is provided.
Disclosure of all financial relationships that the author(s) have with the manufacturer/supplier of any commercial products or services related to the work must be indicated on the abstract submission form. All abstracts will be reviewed via the same process irrespective of these disclosures.
INMIS 2019, with assistance from the Bill & Melinda Gates Foundation and other sponsors, have provided funding for travel bursaries to presenting authors who reside and are conducting research in low and middle income countries (LMICs) as per the Worldbank status. Travel bursaries will cover the registration fee, hotel accommodation and provide travel support from the home country to Vancouver, Canada. Candidates must apply at the time of submission of their abstract on the INMIS Abstract submission page. Applicants will be selected on the basis of the quality of the abstract and availability of funds. Questions about travel bursaries should be addressed to email@example.com
Instructions for booking travel for the travel bursary recipients will be sent to successful applicants in early May, 2019.